Latest News

Meeting Community Needs in Neurology: Insights from the Miami Neuroscience Symposium
Meeting Community Needs in Neurology: Insights from the Miami Neuroscience Symposium

November 6th 2024

Diego Torres-Russotto, MD, chair of neurology at Baptist Health Miami Neuroscience Institute, discussed the Miami Neuroscience Symposium’s focus on addressing the community’s neurological needs, balancing content delivery and fostering multidisciplinary collaboration.

Enhancing Clinical Skills in Physical Medicine and Rehabilitation: Highlights from the Miami Neuroscience Symposium
Enhancing Clinical Skills in Physical Medicine and Rehabilitation: Highlights from the Miami Neuroscience Symposium

November 6th 2024

From Imaging to Innovation: Miami Neuroscience Symposium’s Impact on Modern Neurological Care
From Imaging to Innovation: Miami Neuroscience Symposium’s Impact on Modern Neurological Care

November 6th 2024

NeuroVoices: Richard Nowak, MD, MS, on the MINT Trial of Inebilzumab in Myasthenia Gravis
NeuroVoices: Richard Nowak, MD, MS, on the MINT Trial of Inebilzumab in Myasthenia Gravis

November 6th 2024

FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy
FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy

November 5th 2024

Coverage of the 17th Clinical Trials on Alzheimer's Disease Conference Conference

Get direct access to expert insight and perspective, and all the coverage of the key data presentations, straight from the conference floor in Madrid.

CTAD 2024

Conference Coverage

View All
 Krista L. Lanctôt, PhD
Predicting Response to Cannabinoid Treatment for Agitation in Alzheimer Disease: Krista L. Lanctôt, PhD

November 6th 2024

Giacomo Koch, MD, PhD; Ken Mariash; Emiliano Santarnecchi, PhD
The Promise of Personalized Neurostimulation in Slowing Alzheimer Progression: Giacomo Koch, MD, PhD; Ken Mariash; Emiliano Santarnecchi, PhD

November 6th 2024

NeuroVoices: Richard Nowak, MD, MS, on the MINT Trial of Inebilzumab in Myasthenia Gravis
NeuroVoices: Richard Nowak, MD, MS, on the MINT Trial of Inebilzumab in Myasthenia Gravis

November 6th 2024

Addressing Treatment Gaps in Adolescents With Myasthenia Gravis: Jonathan Strober, MD
Addressing Treatment Gaps in Adolescents With Myasthenia Gravis: Jonathan Strober, MD

November 5th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.